Breaking News Instant updates and real-time market news.

NKE

Nike

$88.05

1.3597 (1.57%)

, FL

Foot Locker

$59.77

0.28 (0.47%)

09:02
03/22/19
03/22
09:02
03/22/19
09:02

Fly Intel: Pre-market Movers

HIGHER: Denbury Resources (DNR), up 5% after mutually agreeing with Penn Virginia (PVAC) to terminate their previously announced merger agreement... Avon Products (AVP), up 5% after the Wall Street Journal reported the company held talks that included a potential deal that Natura would acquire Avon's North American business... Immutep (IMMP), up 44% after being issued a patent that provides intellectual property protection for the company's method of treating cancer by the administration of a chemotherapy agent and a plurality of doses of eftilagimod alpha... Lumentum (LITE), up 4% after JPMorgan analyst Samik Chatterjee upgraded the stock to Overweight from Neutral and raised his price target for the shares to $65 from $50. UP AFTER EARNINGS: Hibbett Sports (HIBB), up 27%. DOWN AFTER EARNINGS: Nike (NKE), down 4.5%. Shares of Foot Locker (FL), a key Nike distributor, are also down nearly 3%... Tiffany (TIF), down 4%... JinkoSolar (JKS), down 5%... Zuora (ZUO), down 10%. LOWER: Sorrento Therapeutics (SRNE), down 1% after announcing that its 77% owned subsidiary Scilex Pharmaceuticals has closed a transaction to merge with Semnur Pharmaceuticals to form a new company, Scilex Holding... Nokia (NOK), down 6% after Reuters reports Finland's data protection ombudsman said he would investigate whether Nokia-branded phones had breached data rules after a report said the handsets sent information to China. Nokia also revealed yesterday in a filing that it has initiated an internal investigation into compliance issues at the former Alcatel Lucent business.

NKE

Nike

$88.05

1.3597 (1.57%)

FL

Foot Locker

$59.77

0.28 (0.47%)

DNR

Denbury Resources

$1.95

0.06 (3.17%)

PVAC

Penn Virginia

$54.29

1.74 (3.31%)

AVP

Avon Products

$2.78

-0.03 (-1.07%)

IMMP

Immutep

$2.40

-0.095 (-3.82%)

LITE

Lumentum

$52.05

2.395 (4.82%)

HIBB

Hibbett Sports

$18.04

-0.46 (-2.49%)

TIF

Tiffany

$100.07

3 (3.09%)

JKS

JinkoSolar

$19.65

-1.91 (-8.86%)

ZUO

Zuora

$24.34

0.62 (2.61%)

SRNE

Sorrento Therapeutics

$5.20

1.71 (49.00%)

NOK

Nokia

$6.26

-0.03 (-0.48%)

  • 22

    Mar

  • 22

    Mar

  • 22

    Mar

  • 28

    Mar

  • 04

    Apr

  • 04

    Apr

  • 15

    Apr

  • 23

    Apr

  • 07

    May

  • 20

    May

  • 24

    May

  • 28

    May

NKE Nike
$88.05

1.3597 (1.57%)

03/22/19
MSCO
03/22/19
NO CHANGE
Target $103
MSCO
Overweight
Nike after-hours pullback a buying opportunity, says Morgan Stanley
Morgan Stanley analyst Lauren Cassel said Nike delivered a strong quarter and she attributes the after-hours pullback in the stock to high buy-side expectations. Cassel, who thinks the company's initial FY20 guidance should be viewed as conservative, sees the after-hours pullback as a buying opportunity. She believes Nike's direct-to-consumer transformation remains in its early innings and views it as one of the few consumer discretionary companies benefiting from the shift to e-commerce. Cassel keeps an Overweight rating and $103 price target on Nike, calling the stock her top pick.
03/22/19
JEFF
03/22/19
NO CHANGE
JEFF
Jefferies continues to prefer Under Armour shares over Nike
Jefferies analyst Randal Konik says Nike (NKE) last night reported a "steady as she goes" quarter with continued market share gains. The analyst, however, keeps a Hold rating on the stock with an $80 price target primarily due to valuation. He prefers shares of Under Armour (UAA, UA) given the "misplaced overly negative sentiment." Konik also views Foot Locker (FL) shares as the best way to play a strengthening Nike business as Nike accounts for 70% of the company's product.
03/22/19
LEHM
03/22/19
NO CHANGE
Target $100
LEHM
Overweight
Nike growth story story 'remains highly intact,' says Barclays
Barclays analyst Matthew McClintock says Nike's long-term growth story "remains highly intact" following last night's fiscal Q3 results. While currency headwinds continue to depress reported results, the core underlying growth rate continues to remain "highly impressive," McClintock tells investors in a post-earnings research note. The analyst is optimistic that Nike's gross margin story is beginning to improve and he keeps an Overweight rating on the shares with a $100 price target.
03/22/19
FBCO
03/22/19
NO CHANGE
FBCO
Outperform
Nike's delivered 'high quality' beat in Q3, says Credit Suisse
Creidt Suisse analyst Michael Binetti backed an Outperform rating on Nike after the company delivered a "high quality" beat for the third quarter. In a research note to investors, Binetti says that while there were "more puts and takes than expected," North America direct to consumer and wholesale both grew mid single digits in Q3, and believes DTC should accelerate in fiscal 2020. Binetti lowered his Q4 EPS view to 62c from 86c on incremental FX pressure and SG&A leverage.
FL Foot Locker
$59.77

0.28 (0.47%)

03/04/19
LEHM
03/04/19
NO CHANGE
Target $85
LEHM
Overweight
Foot Locker price target raised to $85 from $70 at Barclays
Barclays analyst Matthew McClintock raised his price target for Foot Locker to $85 saying the company Friday reported a "close to perfect quarter and achieved what many investors just a few months ago thought was impossible, a 9.7% comp." Further, the analyst continues to believe the Foot Locker growth story is sustainable given recent investments, strong vendor partnerships and a robust pipeline of innovative product. He remains a buyer of the stock following Friday's strength and keeps an Overweight rating on Foot Locker.
03/04/19
03/04/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Foot Locker (FL) upgraded to Buy from Hold at Pivotal Research with analyst Mitch Kummetz saying the company on Friday reported much better than expected Q4 results, and its fiscal 2019 same-store-sales and earnings growth outlook was also well above consensus. 2. Hasbro (HAS) upgraded to Market Perform from Underperform at BMO Capital with analyst Gerrick Johnson saying the stock's multiple will expand as "major theatrical events" approach later in the year. 3. Hertz (HTZ) upgraded to Buy from Neutral at Northcoast. 4. Extended Stay America (STAY) upgraded to Buy from Neutral at Goldman Sachs with analyst Stephen Grambling citing the company's Q4 earnings report. 5. Kraft Heinz (KHC) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Dara Mohsenian saying he believes FY19 estimates now look achievable following their recent correction. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/04/19
BARD
03/04/19
NO CHANGE
Target $77
BARD
Outperform
Foot Locker price target raised to $77 from $65 at Baird
Baird analyst Jonathan Komp raised his price target on Foot Locker to $77 from $65 following its encouraging Q4 performance. He believes the company is well positioned, has an improving outlook, and attractive valuation. The analyst sees a healthy upward bias to valuation, which supports his bullish view, and reiterated his Outperform rating on Foot Locker shares.
DNR Denbury Resources
$1.95

0.06 (3.17%)

12/06/18
SPHN
12/06/18
INITIATION
Target $4
SPHN
Equal Weight
Denbury Resources initiated with an Equal Weight at Stephens
Stephens analysts Gail Nicholson and Drew Lipke began coverage of the E&P sector with a positive outlook, starting Denbury Resources with an Equal Weight rating and $4 price target.
01/08/19
JRCO
01/08/19
DOWNGRADE
JRCO
Hold
Denbury Resources downgraded to Hold from Accumulate at Johnson Rice
12/20/18
SOCO
12/20/18
DOWNGRADE
SOCO
Underweight
Denbury Resources downgraded to Underweight from Overweight at Capital One
03/22/19
NORL
03/22/19
UPGRADE
NORL
Outperform
Penn Virginia upgraded to Outperform on valuation at Northland
Northland analyst Jeff Grampp upgraded Penn Virginia to Outperform from Neutral with an $82 price target following the termination of the Denbury Resources (DNR) merger. Grampp views Penn shares as attractively valued and said the company is well positioned financially.
PVAC Penn Virginia
$54.29

1.74 (3.31%)

12/10/18
NORL
12/10/18
DOWNGRADE
NORL
Market Perform
Penn Virginia downgraded to Market Perform from Outperform at Northland
03/22/19
NORL
03/22/19
UPGRADE
NORL
Outperform
Penn Virginia upgraded to Outperform from Market Perform at Northland
01/09/19
SOCO
01/09/19
DOWNGRADE
SOCO
Equalweight
Penn Virginia downgraded to Equalweight from Overweight at Capital One
AVP Avon Products
$2.78

-0.03 (-1.07%)

09/18/18
DADA
09/18/18
NO CHANGE
DADA
Neutral
Avon CEO likely to get time before board considers sale, says DA Davidson
DA Davidson analyst Linda Bolton Weiser thinks the board of Avon Products (AVP) will give new CEO Jan Zijderveld a period of time to improve financial performance before seriously considering a sale of the company. With Zijderveld set to unveil his turnaround strategy on September 21, the Wall Street Journal reported last night that Brazilian beauty direct seller Natura recently approached Avon about a takeover, Bolton Weiser tells investors in a research note titled "What Will Become of Avon?" Natura said in a statement, however, that there are no negotiations in progress concerning a possible acquisition of Avon, the analyst points out. She doubts that the board and Cerberus would find it prudent to sell the company when the share price is around $2. With that said, Bolton Weiser notes that Avon's takeout valuation is $7.75 per share based on Coty's (COTY) 2012 offer. In April 2012, Coty offered $23.25 per share for Avon, a 27% premium, and later raised it to $24.75 per share, or $10.7B, the analyst recalls. She notes the offer was withdrawn in May 2012. Bolton Weiser has a Neutral rating on Avon Products with a $1.75 price target. The stock in late morning trading is up 8%, or 16c, to $2.24.
09/24/18
DADA
09/24/18
UPGRADE
DADA
Buy
Avon Products upgraded to Buy from Neutral at DA Davidson
09/24/18
DADA
09/24/18
UPGRADE
Target $3.5
DADA
Buy
Avon Products upgraded to Buy at DA Davidson on operational focus of new CEO
As reported earlier, DA Davidson analyst Linda Bolton Weiser upgraded Avon Products (AVP) to Buy from Hold and raised her price target to $3.50 from $1.75. The analyst cites the increased "sense of urgency" under the new CEO Jan Zijderveld displayed in his first analyst meeting, demonstrating his greater engagement in the company's operations, hiring of executives with sales experience, and "establishing a culture of accountability". Based on her increased confidence in Avon's management team, Weiser also raised her target enterprise value to expected FY20 EBITDA target multiple to 6.5-times from 4.5-times, which is still a discount to other direct sellers like Nu Skin (NUS) and Herablife (HLF) trading at 11- to 12-times
09/24/18
09/24/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Plains All American (PAA) and Plains GP Holdings (PAGP) were upgraded to Buy from Hold at Stifel. 2. Avon Products (AVP) upgraded to Buy from Neutral at DA Davidson with analyst Linda Bolton Weiser citing the increased "sense of urgency" under the new CEO Jan Zijderveld displayed in his first analyst meeting, demonstrating his greater engagement in the company's operations, hiring of executives with sales experience, and "establishing a culture of accountability." 3. United Natural Foods (UNFI) upgraded to Sector Perform at RBC Capital with analyst William Kirk saying while core business challenges for the company remain and the risk of the Supervalu acquisition integration continues, its 6.4-times earnings valuation likely accounts for these issues. 4. KVH Industries (KVHI) upgraded to Buy from Neutral at Chardan with analyst James McIlree saying he expects "continued strong growth" from its Agile Plans that should result in improved margins and increased financial predictability. 5. RELX (RELX) upgraded to Overweight from Equal Weight at Barclays with analyst Nick Dempsey saying he views the current valuation as attractive. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
IMMP Immutep
$2.40

-0.095 (-3.82%)

09/28/18
RILY
09/28/18
INITIATION
Target $7.75
RILY
Buy
Immutep initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Dylan Dupuis started Immutep with a Buy rating and $7.75 price target. The analyst views the company as a leader in LAG-3 immunotheraphy.
05/29/18
MAXM
05/29/18
NO CHANGE
Target $7
MAXM
Buy
Immutep price target raised to $7 from $5 at Maxim
Maxim analyst Jason McCarthy raised his price target on Immutep to $7 and kept his Buy rating after the company's announced positive data from the ongoing TACTI-mel study of IMP321. Demonstrating a response rate of 33%, the analyst says the findings validate the IMP321 mechanism of action "and compliment data from the breast cancer study".
LITE Lumentum
$52.05

2.395 (4.82%)

03/22/19
JPMS
03/22/19
UPGRADE
Target $65
JPMS
Overweight
JPMorgan upgrades Lumentum to Overweight on iPhone volume stabilization
JPMorgan analyst Samik Chatterjee upgraded Lumentum Holdings (LITE) to Overweight from Neutral and raised his price target for the shares to $65 from $50. The stock closed yesterday up $2.44, of 5%, to $52.10. The analyst sees a "solid" outlook for the company's telecom business amid "strong" growth led by 5G investments and upside to synergy targets relative to recent acquisition of Oclaro. Further, he sees limited downside risk relative to volume expectations for Apple's (AAPL) iPhone, which he notes has been a "key driver of sentiment on the shares." Stabilization of its iPhone volume outlook should drive focus back to the "strong" fundamentals in Lumentum's primary telecom business, Chatterjee tells investors in a research note.
03/22/19
JPMS
03/22/19
UPGRADE
Target $65
JPMS
Overweight
Lumentum upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Samik Chatterjee upgraded Lumentum Holdings to Overweight from Neutral and raised his price target for the shares to $65 from $50.
01/24/19
PIPR
01/24/19
NO CHANGE
Target $59
PIPR
Overweight
Lumentum price target lowered to $59 from $63 at Piper Jaffray
Piper Jaffray analyst Troy Jensen reduced his 3D sensing and earnings estimates for Lumentum but believes this is already factored into the company's current valuation and should not be a surprise to investors. The analyst continues to view Lumentum as one of the better positioned optical component suppliers and believes its acquisition of Oclaro strengthens the company's position and should lead to industry-leading profitability as cost synergies materialize. As such, despite lowering his price target for the shares to $59 from $63, Jensen reiterates an Overweight rating on Lumentum. The company can grow its 3D sensing segment from "these depressed levels" and show accelerating growth in 2019 and beyond, the analyst tells investors in a research note.
02/06/19
MKMP
02/06/19
NO CHANGE
Target $66
MKMP
Buy
Lumentum price target raised to $66 from $60 at MKM Partners
MKM Partners analyst Michael Genovese raised his price target on Lumentum to $66 and kept his Buy rating after its Q3 results. The analyst says that while earnings missed by a penny, the global ROADM, or reconfigurable optical add-drop multiplexer, demand in U.S. and Europe remains strong, with added momentum coming from the build-out of the Metro networks in China. Genovese contends that Lumentum has "at least a couple more quarters of growth" with no meaningful inventory build happening in ROADMs.
HIBB Hibbett Sports
$18.04

-0.46 (-2.49%)

10/25/18
SUSQ
10/25/18
DOWNGRADE
Target $15
SUSQ
Neutral
Hibbett Sports downgraded to Neutral at Susquehanna
As reported previously, Susquehanna analyst Sam Poser downgraded Hibbett Sports to Neutral from Positive. The analyst believes the company will miss the low end of guidance and Q3 consensus estimates. He also said distribution costs related to digital, and occupancy costs, will likely remain elevated due to poor brick and mortar store performance. Poser lowered his price target to $15 from $25 on Hibbett Sports shares.
03/14/19
BARD
03/14/19
NO CHANGE
Target $16
BARD
Neutral
Hibbett Sports Q4 comps upside likely, says Baird
Baird analyst Peter Benedict kept his Neutral rating and $16 price target on Hibbett Sports ahead of its Q4 earnings, saying indications of improved sector demand and the company's emerging omni-channel capabilities suggest that the comps in the quarter could exceed expectations. The analyst raises his SSS forecast to up 2% from down 0.7%, but warns that material gross margin pressure is likely to constrain earnings. While the stock "looks inexpensive", Benedict believes that a "credible path to stabilize EBIT dollars remains a key hurdle."
03/21/19
CEDG
03/21/19
DOWNGRADE
CEDG
Equal Weight
Hibbett Sports downgraded to Equal Weight from Overweight at Consumer Edge
10/30/18
BARD
10/30/18
NO CHANGE
BARD
Hibbett Sports acquisition of City Gear bolsters urban presence, says Baird
Baird analyst Peter Benedict maintained a Neutral rating on Hibbet Sports. The analyst believes the planned acquisition of City Gear will bolster the company's presence among the younger fashion- forward customers in urban areas, and that the strategic rationale of the transaction makes sense as City Gear is expected to be accretive to EPS next year. However, the analyst also sees "stemming the decline in store comps and EBIT margins at the core-HIBB banner" as a key for the stock, and said visibility on that front was "still low."
TIF Tiffany
$100.07

3 (3.09%)

01/31/19
ATLE
01/31/19
UPGRADE
ATLE
Overweight
Tiffany upgraded to Overweight from Neutral at Atlantic Equities
01/31/19
ATLE
01/31/19
UPGRADE
ATLE
Overweight
Tiffany upgraded to Overweight on valuation at Atlantic Equities
As previously reported, Atlantic Equities analyst Daniela Nedialkova upgraded Tiffany to Overweight from Neutral and maintained a $112 price target on shares. Analyst Nedialkova said the pullback has been largely driven by macro concerns, while fundamentals of the brand are strong and preliminary FY19 guidance is conservative.
01/31/19
01/31/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Pfizer (PFE) upgraded to Outperform from Neutral at Credit Suisse and to Buy from Hold at Argus. 2. Tiffany (TIF) upgraded to Overweight from Neutral at Atlantic Equities with analyst Daniela Nedialkova saying the pullback has been largely driven by macro concerns while fundamentals of the brand are strong and preliminary FY19 guidance is conservative. 3. Scotts Miracle-Gro (SMG) upgraded to Neutral from Underweight at JPMorgan with analyst Jeffrey Zekauskas citing valuation. 4. Geron (GERN) upgraded to Buy from Neutral at B. Riley FBR with analyst George Zavoico saying he believes investors should focus on the pivotal Phase III trial of imetelstat. 5. Ralph Lauren (RL) upgraded to Outperform from Market Perform at Telsey Advisory with analyst Dana Telsey saying the company's improving sakes, combined with ongoing margin expansion, should bolster its earnings. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/22/19
LOOP
01/22/19
NO CHANGE
Target $100
LOOP
Buy
Tiffany making the right investments to become competitive, says Loop Capital
Loop Capital analyst Laura Champine reiterated a Buy rating and $100 price target on Tiffany & Co after meeting with the company's management that focused on its improved planning processes over the past one-to-two years. In a research note to investors, the analyst says that though Tiffany's sales clearly swing with the market's fortunes and geopolitical events, she thinks the company is making the right investments to become more competitive and hold and eventually gain share in the branded jewelry industry. Champine says she believes her new FY19 EPS estimate of $4.83 is "conservative" given the potential for margin expansion this year, though this is likely to be somewhat offset by a higher tax rate and changes in lease amortization accounting rules.
JKS JinkoSolar
$19.65

-1.91 (-8.86%)

03/06/19
VERF
03/06/19
NO CHANGE
VERF
Sell
JinkoSolar a 'screaming short' given debt obligations, says Vertical Group
Vertical Group analyst Gordon Johnson said in an email that he believes JinkoSolar is a "screaming short" given that the company has not denied they are obligated for Jinko Power's "suspended" $299M bond offering, replying only that they "believe Jinko Power will be able to raise debt this year." In his email, Johnson added: "If they're wrong, which they were when Jinko Power tried to issue debt earlier this year, you're talking about an unknown debt liability the size of JKS' market cap (yes, you heard that right)." Johnson has a Sell rating on JinkoSolar shares.
02/04/19
02/04/19
UPGRADE
Target $20

Buy
JinkoSolar upgraded to Buy at Roth Capital on global demand strength
As previously reported, Roth Capital analyst Philip Shen upgraded JinkoSolar to a Buy from a Neutral on global demand strength ex-China. The analyst expects tight module supply to drive pricing modestly higher in the U.S. and around the world. With costs likely muted/low and ASPs moving up, Shen takes up his 2019/2020 estimates and sees greater earnings power ahead. The analyst also raised his price target on the shares to $20 from $11.50 as he continues to see upside for the stock.
12/19/18
12/19/18
INITIATION

JinkoSolar initiated with a Sell at Williams Research
Williams Research Partners started JinkoSolar with a Sell rating and $1 price target.
02/04/19
ROTH
02/04/19
UPGRADE
ROTH
Buy
JinkoSolar upgraded to Buy from Neutral at Roth Capital
ZUO Zuora
$24.34

0.62 (2.61%)

03/22/19
JEFF
03/22/19
NO CHANGE
Target $35
JEFF
Buy
Zuora business metrics strong, growth sustainable, says Jefferies
Zuora exceeded fiscal Q4 sales and met profit expectations, with similar characteristics for its Q1 guidance, "though prudent annual subscription guidance was a touch shy," Jefferies analyst John DiFucci tells investors in a research note. Zuora's business metrics were strong, and while subscription growth of 35% decelerated modestly it was against the most difficult comp this year, the analyst adds. He continues to believe the "subscription economy" will drive a growth rate of at least 25%-30% over the next five-to-ten years for Zuora. DiFucci keeps a Buy rating on the shares with a $35 price target
03/20/19
NEED
03/20/19
NO CHANGE
Target $30
NEED
Strong Buy
Zuora price target raised to $30 from $27 at Needham
Needham analyst Scott Berg raised his price target on Zuora to $30 and kept his Strong Buy rating ahead of its Q4 results, saying his forecasts suggest that earnings will top expectations. The analyst cites strengthening in the company's technology and media verticals and anticipates that the company to "sustain the high 20% to 30% growth profile for several years". Berg also expects Zuora to reduce its free cash flow burn by about $10M per year.
03/19/19
03/19/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Noble Energy (NBL) upgraded to Buy from Neutral at Mizuho with analyst Paul Sankey stating the company's upcoming free cash flow inflection "is too close to ignore." 2. Domino's Pizza (DPZ) upgraded to Overweight from Neutral at JPMorgan with analyst John Ivankoe saying he believes Domino's algorithm to achieve 8%-12% system-wide sales growth remains intact. 3. Zuora (ZUO) upgraded to Buy from Hold at Canaccord with analyst Richard Davis citing favorable long-term prospects. 4. Five Below (FIVE) upgraded to Buy from Hold at Loop Capital with analyst Anthony Chukumba saying the company's ability to "comp the comp" has been impressive. 5. 1-800-Flowers.com (FLWS) upgraded to Buy from Neutral at DA Davidson with analyst Linda Bolton Weiser citin the company's continued market share gains. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here
03/22/19
ADAM
03/22/19
NO CHANGE
Target $28
ADAM
Buy
Zuora pullback a buying opportunity, says Canaccord
Canaccord analyst Richard Davis said "there was absolutely nothing" he heard on Zuora's earnings call or his call back with management that shakes his confidence in his Buy recommendation and he suggests investors use the post-earnings pullback to fill out positions. Commentary on the call about large deal growth, transaction volumes on platform and net dollar retention were all positive, noted Davis, who continues to believe Zuora is capable of growing faster for longer than some investors expect. He maintains a Buy rating and $28 price target on Zuora shares.
SRNE Sorrento Therapeutics
$5.20

1.71 (49.00%)

12/12/18
HCWC
12/12/18
NO CHANGE
HCWC
Buy
Sorrento Therapeutics has multiple catalysts in 2019, says H.C. Wainwright
2019 should represent a turning point for Sorrento Therapeutics, H.C. Wainwright analyst Raghuram Selvaraju tells investors in a research note. The analyst believes the company is in position to report "multiple value-driving clinical data catalysts" over the course of 2019, both with its pain management portfolio and its cancer immunotherapy candidates. He thinks the interest in anti-CD38 CAR-T approaches has only increased following the recently concluded American Society for Hematology annual meeting. Further, Sorrento's recent financing transactions "provide a pathway to sustainability," adds Selvaraju. He reiterates a Buy rating on the shares with a $40 price target.
03/20/19
RILY
03/20/19
NO CHANGE
Target $12
RILY
Buy
B. Riley FBR boosts Sorrento target to $12, sees 'numerous' catalysts
B. Riley FBR analyst Andrew D'Silva raised his price target for Sorrento Therapeutics to $12.00 from $10.50 and maintains a Buy rating on the shares following the company's Q4 results. Following the "strong close to 2018," the analyst lowered his cash burn estimates and pushed out projected capital raises. The top- and bottom-line beats were due to higher sales and services revenue, primarily out of Scilex Pharmaceuticals, the company's majority-owned subsidiary, as ZTlido sales were recognized a quarter earlier than expected, D'Silva tells investors in a research note. The analyst, however, continues to believe the primary driving force of Sorrento's share price is "locked in its product pipeline." With "numerous high-value opportunities" that primarily extend across immuno-oncology, pain management, and animal health, D'Silva sees a positive risk/reward on the stock.
04/03/18
HCWC
04/03/18
NO CHANGE
Target $40
HCWC
Buy
Sorrento target raised to $40 after completed financing at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju raised his price target for Sorrento Therapeutics to $40 from $38 saying the recently completed convertible note financing "provides ample runway." The company now has a sufficient cash runway to fund operations for at least the next 24 months, which removes a near-term overhang, Selvaraju tells investors in a research note. He reiterates a Buy rating on Sorrento.
06/28/18
RILY
06/28/18
INITIATION
Target $14.25
RILY
Buy
Sorrento Therapeutics initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Andrew D'Silva started Sorrento Therapeutics with a Buy rating and $14.25 price target.
NOK Nokia
$6.26

-0.03 (-0.48%)

02/01/19
ADAM
02/01/19
NO CHANGE
Target $8
ADAM
Buy
Nokia results show targets and thesis intact, says Canaccord
Canaccord analyst T. Michael Walkley noted Nokia reported Q4 results consistent with his estimates. He believes the company is positioned as a long-term industry leader as 5G begins to ramp. The analyst said his Buy thesis and the company's 2020 targets remain intact. Walkley reiterated his Buy rating and raised his price target to $7.50 from $7.00 on Nokia shares.
03/20/19
NORD
03/20/19
DOWNGRADE
NORD
Hold
Nokia downgraded to Hold from Buy at Nordea
01/23/19
MKMP
01/23/19
NO CHANGE
Target $7.5
MKMP
Buy
Nokia Q4 earnings should be solid, says MKM Partners
MKM Partners analyst Michael Genovese kept his Buy rating and $7.50 price target on Nokia (NOK) ahead of its Q4 results, saying that earnings should be solid with evidence of 5G contribution, even though the outlook on its potential "won't settle the debate". The analyst notes that T-Mobile's (TMUS) 5G network build demand should also yield a good Q1 outlook with added contribution coming from the accelerated 5G plans from KT (KT) and SK Telecom in South Korea. Genovese adds that the 5G debate centers around investment plans by AT&T (T) and Verizon (VZ), but his checks indicate that the former has not made any final decisions on the timing.
01/08/19
RAJA
01/08/19
UPGRADE
Target $7.5
RAJA
Outperform
Nokia upgraded to Outperform at Raymond James
As previously reported, Raymond James upgraded Nokia to Outperform from Market Perform with a $7.50 price target. Analyst Simon Leopold sees improving trends led by wireless spending that will aid Nokia's other segments of routing, optical and mobility. Simon also expects Nokia to benefit from the global backlash against Huawei, and views the company as advantaged given the diversity of its portfolio.

TODAY'S FREE FLY STORIES

UPS

UPS

$120.71

1.61 (1.35%)

21:22
09/20/19
09/20
21:22
09/20/19
21:22
Conference/Events
UPS management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

DIS

Disney

$132.18

-1.14 (-0.86%)

, T

AT&T

$37.92

0.78 (2.10%)

18:17
09/20/19
09/20
18:17
09/20/19
18:17
Periodicals
Disney reaches TV carriage agreement with AT&T, Bloomberg says »

The deal includes ESPN on…

DIS

Disney

$132.18

-1.14 (-0.86%)

T

AT&T

$37.92

0.78 (2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

BA

Boeing

$379.33

-5.28 (-1.37%)

18:15
09/20/19
09/20
18:15
09/20/19
18:15
Periodicals
Icelandair reaches deal for Boeing to cover costs associated with 737, WSJ says »

Icelandair Group said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

MCF

Contango Oil & Gas

$1.71

-0.07 (-3.93%)

17:58
09/20/19
09/20
17:58
09/20/19
17:58
Hot Stocks
Karlin Asset Management reports 11.4% passive stake in Contango Oil & Gas »

Karlin Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Shares

$142.97

1.68 (1.19%)

17:41
09/20/19
09/20
17:41
09/20/19
17:41
Hot Stocks
SPDR Gold Shares holdings rise to 894.15MT from 883.60MT »

This is the highest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VXRT

Vaxart

$0.58

-0.0307 (-5.03%)

17:37
09/20/19
09/20
17:37
09/20/19
17:37
Syndicate
Vaxart files to sell 15.6M shares of common stock »

H.C. Wainwright acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.69

-3.22 (-1.46%)

17:34
09/20/19
09/20
17:34
09/20/19
17:34
Periodicals
Apple given tariff exclusion on certain Mac Pro parts, Bloomberg says »

Apple has received U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IIVI

II-VI

$39.05

-0.5 (-1.26%)

, CPE

Callon Petroleum

$4.53

-0.015 (-0.33%)

17:31
09/20/19
09/20
17:31
09/20/19
17:31
Hot Stocks
II-VI to enter S&P 400; Callon Petroleum, PriceSmart to enter S&P SmallCap600 »

S&P SmallCap 600…

IIVI

II-VI

$39.05

-0.5 (-1.26%)

CPE

Callon Petroleum

$4.53

-0.015 (-0.33%)

PSMT

PriceSmart

$60.29

-0.39 (-0.64%)

FNSR

Finisar

$24.31

1.25 (5.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 02

    Oct

  • 30

    Oct

NVR

NVR

$3,632.55

-30.45 (-0.83%)

, JEF

Jefferies Financial Group

$19.47

-0.19 (-0.97%)

17:26
09/20/19
09/20
17:26
09/20/19
17:26
Hot Stocks
NVR to replace Jefferies Financial Group in the S&P 500 at open on September 26 »

NVR (NVR) will replace…

NVR

NVR

$3,632.55

-30.45 (-0.83%)

JEF

Jefferies Financial Group

$19.47

-0.19 (-0.97%)

SPB

Spectrum Brands

$49.66

-1.395 (-2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

NOC

Northrop Grumman

$368.25

-7.45 (-1.98%)

17:24
09/20/19
09/20
17:24
09/20/19
17:24
Hot Stocks
Northrop Grumman subsidiary awarded $1.12B Missile Defense Agency contract »

Orbital Sciences, or OSC,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSMT

PriceSmart

$60.29

-0.39 (-0.64%)

, FNSR

Finisar

$24.31

1.25 (5.42%)

17:23
09/20/19
09/20
17:23
09/20/19
17:23
Hot Stocks
Breaking Hot Stocks news story on PriceSmart, Finisar »

PriceSmart to replace…

PSMT

PriceSmart

$60.29

-0.39 (-0.64%)

FNSR

Finisar

$24.31

1.25 (5.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

IIVI

II-VI

$39.05

-0.5 (-1.26%)

, CPE

Callon Petroleum

$4.53

-0.015 (-0.33%)

17:22
09/20/19
09/20
17:22
09/20/19
17:22
Hot Stocks
Breaking Hot Stocks news story on II-VI, Callon Petroleum »

II-VI to replace Callon…

IIVI

II-VI

$39.05

-0.5 (-1.26%)

CPE

Callon Petroleum

$4.53

-0.015 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 02

    Oct

NVR

NVR

$3,632.55

-30.45 (-0.83%)

17:20
09/20/19
09/20
17:20
09/20/19
17:20
Hot Stocks
Breaking Hot Stocks news story on NVR »

NVR to replace Jefferies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NHYDY

Norsk Hydro

$0.00

(0.00%)

17:12
09/20/19
09/20
17:12
09/20/19
17:12
Hot Stocks
Norsk Hydro discloses federal court in Brazil lifts embargo on Alunortes »

The Federal Court in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RESN

Resonant

$3.05

0.02 (0.66%)

17:03
09/20/19
09/20
17:03
09/20/19
17:03
Conference/Events
Resonant participates in a conference call with Loop Capital »

Semiconductor Analysts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 12

    Nov

NINE

Nine Energy Services

$6.73

-0.33 (-4.67%)

17:02
09/20/19
09/20
17:02
09/20/19
17:02
Syndicate
Breaking Syndicate news story on Nine Energy Services »

Nine Energy Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATOM

Atomera

$3.70

0.17 (4.82%)

17:00
09/20/19
09/20
17:00
09/20/19
17:00
Conference/Events
Atomera participates in a conference call with Loop Capital »

Semiconductor Analysts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPWR

Monolithic Power

$154.21

-2 (-1.28%)

16:50
09/20/19
09/20
16:50
09/20/19
16:50
Conference/Events
Monolithic Power participates in a conference call with Loop Capital »

Semiconductor Analysts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

AAPL

Apple

$217.69

-3.22 (-1.46%)

16:45
09/20/19
09/20
16:45
09/20/19
16:45
Periodicals
Breaking Periodicals news story on Apple »

Apple given tariff…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDA

IDACORP

$111.26

0.93 (0.84%)

16:36
09/20/19
09/20
16:36
09/20/19
16:36
Hot Stocks
IDACORP raises quarterly dividend to 67c from 63c per share »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

MO

Altria Group

$40.80

0.69 (1.72%)

16:33
09/20/19
09/20
16:33
09/20/19
16:33
Hot Stocks
Altria Group recommends rejection of amended mini-tender by TRC »

Altria Group states it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$0.00

(0.00%)

, AL

Air Lease

$42.68

-0.615 (-1.42%)

16:32
09/20/19
09/20
16:32
09/20/19
16:32
Hot Stocks
Air Lease announces delivery of new A321-200neo to Air Astana »

Air Lease Corporation…

EADSY

Airbus

$0.00

(0.00%)

AL

Air Lease

$42.68

-0.615 (-1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

16:30
09/20/19
09/20
16:30
09/20/19
16:30
Options
Preliminary option volume of 23.5M today »

Preliminary option volume…

PSX

Phillips 66

$103.26

0.14 (0.14%)

16:28
09/20/19
09/20
16:28
09/20/19
16:28
Periodicals
Phillips 66 says Beaumont oil terminal ops still shut down, Reuters says »

Phillips 66 said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

POST

Post Holdings

$105.73

0.335 (0.32%)

16:24
09/20/19
09/20
16:24
09/20/19
16:24
Hot Stocks
Post files IPO for active nutrition unit BellRing Brands »

Post Holdings, Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.